Fig. 2

Transition from FIONA to FIONA OLE study. Dagger indicates the key list of inclusion and exclusion criteria that must be fulfilled can be found in Table 1 and 2. eCRF electronic case report form, eGFR estimated glomerular filtration rate, EOT end of treatment, K + potassium, OLE open-label extension, TEAE treatment-emergent adverse event